| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |